tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Balancing Near-Term Headwinds and Strategic Transition: Why a Hold Rating Remains Warranted
PremiumRatingsBalancing Near-Term Headwinds and Strategic Transition: Why a Hold Rating Remains Warranted
11d ago
BioNTech: Attractive Near-Cash Valuation with Robust Late-Stage Pipeline Offsetting Revenue Declines and Leadership Transition Risks
Premium
Ratings
BioNTech: Attractive Near-Cash Valuation with Robust Late-Stage Pipeline Offsetting Revenue Declines and Leadership Transition Risks
11d ago
Jefferies cuts BioNTech price target, says stock is cheap
Premium
The Fly
Jefferies cuts BioNTech price target, says stock is cheap
11d ago
Morning Movers: BioNTech sinks following departure of founders, Q4 results
PremiumThe FlyMorning Movers: BioNTech sinks following departure of founders, Q4 results
11d ago
BioNTech Posts 2025 Loss but Leans on Strong Cash and Late-Stage Oncology Pipeline
Premium
Company Announcements
BioNTech Posts 2025 Loss but Leans on Strong Cash and Late-Stage Oncology Pipeline
11d ago
BioNTech Co-Founders to Launch Independent mRNA Venture as Company Refocuses on Late-Stage Pipeline
Premium
Company Announcements
BioNTech Co-Founders to Launch Independent mRNA Venture as Company Refocuses on Late-Stage Pipeline
11d ago
Palantir upgraded, Best Buy downgraded: Wall Street’s top analyst calls
PremiumThe FlyPalantir upgraded, Best Buy downgraded: Wall Street’s top analyst calls
2M ago
Leerink downgrades BioNTech to Market Perform following ‘successful rally’
Premium
The Fly
Leerink downgrades BioNTech to Market Perform following ‘successful rally’
2M ago
BioNTech downgraded to Market Perform from Outperform at Leerink
Premium
The Fly
BioNTech downgraded to Market Perform from Outperform at Leerink
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100